ABSTRACT
We present the case of a patient with subarachnoid hemorrhage (SAH) secondary to a ruptured cerebral aneurysm and a refractory shock with high doses of vasopressors without a proven source of infection. This patient received therapy with high-volume hemofiltration plus adsorption, resolving the hemodynamic deterioration and with good neurological evolution. Our clinical case proposes that extracorporeal therapies may have a feasibility role in the management of complications of SAH.
Subject(s)
Hemofiltration , Subarachnoid Hemorrhage/therapy , Hemofiltration/instrumentation , Humans , Interleukin-6/blood , Intracranial Aneurysm/blood , Intracranial Aneurysm/complications , Intracranial Aneurysm/therapy , Male , Middle Aged , Subarachnoid Hemorrhage/blood , Subarachnoid Hemorrhage/complicationsABSTRACT
We present the case of a patient who suffered from acute respiratory distress syndrome caused by pneumonia associated with COVID-19 and cytokine release syndrome. This patient received a high-volume hemofiltration plus adsorption, solving the hemodynamic deterioration, pulmonary infiltrates, and gas exchange. Our clinical case proposes that the extracorporeal therapies can have a role in the management of severe COVID-19.